Role of chemotherapy in the management of advanced thymic tumors

Seminars in Thoracic and Cardiovascular Surgery

Volumn 17, Issue 1, 2005, Pages 41-50

  Evans, Tracey L ^a   Lynch, Thomas J ^b  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Chemotherapy; Thymic carcinoma; Thymoma

Indexed keywords

BLEOMYCIN; CISPLATIN; CORTICOSTEROID; CORTICOTROPIN; CYCLOPHOSPHAMIDE; DEXAMETHASONE; DOXORUBICIN; EPIRUBICIN; ETOPOSIDE; GRANULOCYTE COLONY STIMULATING FACTOR; IFOSFAMIDE; INTERLEUKIN 2; MESNA; NEDAPLATIN; OCTREOTIDE; PREDNISONE; VINCRISTINE;

ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER GROWTH; CANCER PALLIATIVE THERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; DRUG EFFICACY; HEART DISEASE; HUMAN; INTERMETHOD COMPARISON; MEDICAL SPECIALIST; METASTASIS INHIBITION; MULTIMODALITY CANCER THERAPY; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; POSTOPERATIVE PERIOD; PROGNOSIS; RECURRENCE RISK; STERNOTOMY; SYMPTOM; THORACOTOMY; THORAX SURGERY; THYMECTOMY; THYMOMA; THYMUS CANCER; TREATMENT OUTCOME;

EID: 17144390210     PISSN: 10430679     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.semtcvs.2004.11.003     Document Type: Review

References (46)

1. F.C. Detterbeck A.M. Parsons Thymic tumors Ann Thorac Surg 77 2004 1860-1869
2. W.J. Curran Jr M.J. Kornstein J.J. Brooks et al. Invasive thymoma: The role of mediastinal irradiation following complete or incomplete surgical resection J Clin Oncol 6 1988 1722-1727
3. A.A. Mangi C.D. Wright J.S. Allan et al. Adjuvant radiation therapy for stage II thymoma Ann Thorac Surg 74 2002 1033-1037
4. G. Maggi C. Casadio A. Cavallo et al. Thymoma: Results of 241 operated cases Ann Thorac Surg 51 1991 152-156
5. D. Blumberg J.L. Port B. Weksler et al. Thymoma: A multivariate analysis of factors predicting survival Ann Thorac Surg 60 1995 908-913 discussion 914, 1995
6. D. Cowen P. Richaud F. Mornex et al. FNCLCC trialists Federation Nationale des Centres de Lutte Contre le Cancer Thymoma: Results of a multicentric retrospective series of 149 non-metastatic irradiated patients and review of the literature Radiother Oncol 34 1995 9-16
7. G. Maggi G. Giaccone M. Donadio et al. Thymomas. A review of 169 cases, with particular reference to results of surgical treatment Cancer 58 1986 765-776
8. K. Kondo Y. Monden Therapy for thymic epithelial tumors: A clinical study of 1,320 patients from Japan Ann Thorac Surg 76 2003 878-884
9. P. Strobel A. Bauer B. Puppe et al. Tumor recurrence and survival in patients treated for thymomas and thymic squamous cell carcinomas: A retrospective analysis J Clin Oncol 22 2004 1501-1509
10. J.F. Mackintosh G.A. Hawson K.S. Matar et al. Initial chemotherapy followed by surgery in malignant thymoma Aust N Z J Med 19 1989 362-364
11. P. Macchiarini A. Chella F. Ducci et al. Neoadjuvant chemotherapy, surgery, and postoperative radiation therapy for invasive thymoma Cancer 68 1991 706-713
12. F. Rea F. Sartori M. Loy et al. Chemotherapy and operation for invasive thymoma J Thorac Cardiovasc Surg 106 1993 543-549
13. D.M. Shin G.L. Walsh R. Komaki et al. A multidisciplinary approach to therapy for unresectable malignant thymoma Ann Intern Med 129 1998 100-104
14. E.S. Kim J.B. Putnam R. Komaki et al. Phase II study of a multidisciplinary approach with induction chemotherapy, followed by surgical resection, radiation therapy, and consolidation chemotherapy for unresectable malignant thymomas: Final report Lung Cancer 44 2004 369-379
15. F. Mornex M. Resbeut P. Richaud et al. The FNCLCC trialists Federation Nationale des Centres de Lutte Contre le Cancer Radiotherapy and chemotherapy for invasive thymomas: A multicentric retrospective review of 90 cases Int J Radiat Oncol Biol Phys 32 1995 651-659
16. R. Arriagada J.J. Bretel J.M. Caillaud et al. Invasive carcinoma of the thymus. A multicenter retrospective review of 56 cases Eur J Cancer Clin Oncol 20 1984 69-74
17. F. Venuta E.A. Rendina E.O. Pescarmona et al. Multimodality treatment of thymoma: A prospective study Ann Thorac Surg 64 1997 1585-1591
18. F. Venuta E.A. Rendina F. Longo et al. Long-term outcome after multimodality treatment for stage III thymic tumors Ann Thorac Surg 76 2003 1866-1872 discussion 1872, 2003
19. P.J. Loehrer Sr. M. Chen K. Kim et al. Cisplatin, doxorubicin, and cyclophosphamide plus thoracic radiation therapy for limited-stage unresectable thymoma: An intergroup trial J Clin Oncol 15 1997 3093-3099
20. B. Boston Chemotherapy of invasive thymoma Cancer 38 1976 49-52
21. P.J. Loehrer W. Wang S. Aisner et al. Long-term follow-up of patients with locally advanced or metastatic thymic malignancies: The Eastern Cooperative Oncology Group (ECOG) experience 2004 Proceedings of the American Society of Clinical Oncology Annual Meeting, New Orleans, LA; abstract #7050
22. P.J. Loehrer Sr. K. Kim S.C. Aisner et al. The Eastern Cooperative Oncology Group, Southwest Oncology Group, and Southeastern Cancer Study Group Cisplatin plus doxorubicin plus cyclophosphamide in metastatic or recurrent thymoma: Final results of an intergroup trial J Clin Oncol 12 1994 1164-1168
23. A. Fornasiero O. Daniele C. Ghiotto et al. Chemotherapy for invasive thymoma. A 13-year experience Cancer 68 1991 30-33
24. M.S. Highley C.R. Underhill F.X. Parnis et al. Treatment of invasive thymoma with single-agent ifosfamide J Clin Oncol 17 1999 2737-2744
25. P.J. Loehrer Sr. M. Jiroutek S. Aisner et al. Combined etoposide, ifosfamide, and cisplatin in the treatment of patients with advanced thymoma and thymic carcinoma: An intergroup trial Cancer 91 2001 2010-2015
26. P.N. Lara Jr P.D. Bonomi L.P. Faber Retreatment of recurrent invasive thymoma with platinum, doxorubicin, and cyclophosphamide Chest 110 1996 1115-1117
27. N. Hanna V.S. Gharpure R. Abonour et al. High-dose carboplatin with etoposide in patients with recurrent thymoma: The Indiana University experience Bone Marrow Transplant 28 2001 435-438
28. E. Hu J. Levine Chemotherapy of malignant thymoma. Case report and review of the literature Cancer 57 1986 1101-1104
29. C. Kirkove J. Berghmans H. Noel et al. Dramatic response of recurrent invasive thymoma to high doses of corticosteroids Clin Oncol (R Coll Radiol) 4 1992 64-66
30. A. Basha P.D. Bonomi Glucocorticoid therapy for invasive thymoma progressing after chemotherapy: A review of 4 cases 2002 Proceedings of the American Society of Clinical Oncology, Orlando, FL, 238b
31. P. Berthaud T. Le Chevalier T. Tursz Effectiveness of interleukin-2 in invasive lymphoepithelial thymoma Lancet 335 1990 1590
32. M.S. Gordon L.A. Battiato R. Gonin et al. A phase II trial of subcutaneously administered recombinant human interleukin-2 in patients with relapsed/refractory thymoma J Immunother Emphasis Tumor Immunol 18 1995 179-184
33. R.V. La Rocca M.R. Cooper R. Danesi et al. Suramin therapy for malignant thymoma: A case report Eur J Cancer 30A 1994 718-719
34. S. Lastoria E. Vergara G. Palmieri et al. In vivo detection of malignant thymic masses by indium-111-DTPA-D-Phe1-octreotide scintigraphy J Nucl Med 39 1998 634-639
35. D. Ferone P.M. van Hagen P.M. van Koetsveld et al. In vitro characterization of somatostatin receptors in the human thymus and effects of somatostatin and octreotide on cultured thymic epithelial cells Endocrinology 140 1999 373-380
36. G. Palmieri S. Lastoria A. Colao et al. Successful treatment of a patient with a thymoma and pure red-cell aplasia with octreotide and prednisone N Engl J Med 336 1997 263-265
37. P.J. Loehrer Sr W. Wang D.H. Johnson et al. Octreotide alone or with prednisone in patients with advanced thymoma and thymic carcinoma: An Eastern Cooperative Oncology Group Phase II Trial J Clin Oncol 22 2004 293-299
38. S. Suster J. Rosai Thymic carcinoma. A clinicopathologic study of 60 cases Cancer 67 1991 1025-1032
39. C.P. Hsu C.Y. Chen C.L. Chen et al. Thymic carcinoma. Ten years' experience in twenty patients J Thorac Cardiovasc Surg 107 1994 615-620
40. A. Kitami T. Suzuki Y. Kamio et al. Chemotherapy of thymic carcinoma: Analysis of seven cases and review of the literature Jpn J Clin Oncol 31 2001 601-604
41. L.G. Weide T.M. Ulbright P.J. Loehrer Sr et al. Thymic carcinoma. A distinct clinical entity responsive to chemotherapy Cancer 71 1993 1219-1223
42. M. Lucchi A. Mussi F. Basolo et al. The multimodality treatment of thymic carcinoma Eur J Cardiothorac Surg 19 2001 566-569
43. P.D. Bonomi D. Finkelstein S. Aisner et al. EST 2582 phase II trial of cisplatin in metastatic or recurrent thymoma Am J Clin Oncol 16 1993 342-345
44. G. Giaccone A. Ardizzoni A. Kirkpatrick et al. Cisplatin and etoposide combination chemotherapy for locally advanced or metastatic thymoma. A phase II study of the European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group J Clin Oncol 14 1996 814-820
45. F. Oshita T. Kasai T. Kurata et al. Intensive chemotherapy with cisplatin, doxorubicin, cyclophosphamide, etoposide and granulocyte colony-stimulating factor for advanced thymoma or thymic cancer: Preliminary results Jpn J Clin Oncol 25 1995 208-212
46. P.A. Kosmidis E. Iliopoulos S. Pentea Combination chemotherapy with cyclophosphamide, adriamycin, and vincristine in malignant thymoma and myasthenia gravis Cancer 61 1988 1736-1740